Telomir Pharmaceuticals, Common Stock Technical Analysis
| TELO Stock | 4.28 0.17 3.82% |
As of the 29th of November, Telomir Pharmaceuticals, has the Variance of 54.76, risk adjusted performance of 0.0027, and Coefficient Of Variation of (12,176). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telomir Pharmaceuticals,, as well as the relationship between them.
Telomir Pharmaceuticals, Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Telomir, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TelomirTelomir |
Telomir Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Telomir Pharmaceuticals, Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Telomir Pharmaceuticals, volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Telomir Pharmaceuticals, Trend Analysis
Use this graph to draw trend lines for Telomir Pharmaceuticals, Common. You can use it to identify possible trend reversals for Telomir Pharmaceuticals, as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Telomir Pharmaceuticals, price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Telomir Pharmaceuticals, Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Telomir Pharmaceuticals, Common applied against its price change over selected period. The best fit line has a slop of 0.04 , which may suggest that Telomir Pharmaceuticals, Common market price will keep on failing further. It has 122 observation points and a regression sum of squares at 72.53, which is the sum of squared deviations for the predicted Telomir Pharmaceuticals, price change compared to its average price change.About Telomir Pharmaceuticals, Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Telomir Pharmaceuticals, Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Telomir Pharmaceuticals, Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Telomir Pharmaceuticals, price pattern first instead of the macroeconomic environment surrounding Telomir Pharmaceuticals,. By analyzing Telomir Pharmaceuticals,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Telomir Pharmaceuticals,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Telomir Pharmaceuticals, specific price patterns or momentum indicators. Please read more on our technical analysis page.
Telomir Pharmaceuticals, November 29, 2024 Technical Indicators
Most technical analysis of Telomir help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Telomir from various momentum indicators to cycle indicators. When you analyze Telomir charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0027 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 5.17 | |||
| Coefficient Of Variation | (12,176) | |||
| Standard Deviation | 7.4 | |||
| Variance | 54.76 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (1.18) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 39.54 | |||
| Value At Risk | (8.91) | |||
| Potential Upside | 11.67 | |||
| Skewness | 1.82 | |||
| Kurtosis | 6.17 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.84) | Return On Equity (6.87) |
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.